Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the future of gene editing.
CRISPR Therapeutics is the first company to secure an FDA approval of a gene-editing drug. That drug's underlying science, however, could be used to create treatments for any number of genetically ...
(Nanowerk News) In a major step forward for cancer care, researchers at ChristianaCare’s Gene Editing Institute have shown that disabling the NRF2 gene with CRISPR technology can reverse chemotherapy ...
Rice (Oryza sativa L.) feeds over half of the global population and is central to food security across Asia, Africa, and the Americas. To meet the world’s growing demand, breeders are pursuing ideal ...
Growing revenues from Casgevy will help CRISPR Therapeutics fund the development of its pipeline therapies. The gene-editing biotech isn't profitable yet. CRISPR Therapeutics has a deep pipeline of ...
Torie Bosch is the First Opinion editor at STAT. Celena Lozano’s son Benny, who turned 5 in November, loves trains, trucks — anything that goes. He also has a rare disease, PURA syndrome. Earlier this ...
In a major step forward for cancer care, researchers at ChristianaCare’s Gene Editing Institute have shown that disabling the NRF2 gene with CRISPR technology can reverse chemotherapy resistance in ...
CRISPR Therapeutics has some promising and innovative pipeline candidates. The stock will soar if it can execute and deliver strong clinical and regulatory progress. CRISPR Therapeutics has lagged the ...
(Nanowerk News) The Molecular Microbiology research group at the University of Alicante (UA) has identified a new enzyme with promising properties for CRISPR-Cas gene editing tools. Named AlCas12a, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results